Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
Globe Newswire•13/11/2026•09:16 ET
0
Key Highlights
- ➤AlterG revenue rose 18% year-over-year to $3.6 million
- ➤Q3 revenue fell 12% year-over-year to $5.4 million
- ➤ReWalk revenue declined to $1.7 million from $3.0 million
- ➤Lifeward is shifting ReWalk sales to channel-partner distribution
- ➤Gross margin dropped to 27.4% from 43.7% year-over-year
Expert Statements
Josh Hexter, Interim Chief Executive Officer of Lifeward
“The third quarter was a transitional quarter for Lifeward, marked by continued AlterG growth as we move into the advanced stages of transitioning ReWalk to a channel-partner distribution model. Moving away from direct sales can create timing gaps in the near term, but we believe partnering with established providers that already reach patients nationwide is the right path to significantly expand access to ReWalk and accelerate revenue growth over the long term.”
AlterG revenue increased 18% year-over-year to $3.6 million, driven by higher U.S. unit shipments, service revenue and average selling prices
The Company is advancing its transition of ReWalk to a capital-efficient channel-partner distribution model designed to expand patient access and support long-term revenue growth
Get started
Create a free account to read the full story.